These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11093361)

  • 41. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.
    Zucker S; Cao J; Chen WT
    Oncogene; 2000 Dec; 19(56):6642-50. PubMed ID: 11426650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Histone deacetylase inhibitors in cancer therapy.
    Fouladi M
    Cancer Invest; 2006; 24(5):521-7. PubMed ID: 16939962
    [No Abstract]   [Full Text] [Related]  

  • 43. Alternatives to chemotherapy and radiotherapy in the treatment of small cell lung cancer.
    Shepherd FA
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):30-7. PubMed ID: 11479895
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A phase I and pharmacological study of the matrix metalloproteinase inhibitor BB-3644 in patients with solid tumours.
    Wall L; Talbot DC; Bradbury P; Jodrell DI
    Br J Cancer; 2004 Feb; 90(4):800-4. PubMed ID: 14970856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phase II study of marimastat (BB-2516) in malignant melanoma: a clinical and tumor biopsy study of the National Cancer Institute of Canada Clinical Trials Group.
    Quirt I; Bodurth A; Lohmann R; Rusthoven J; Belanger K; Young V; Wainman N; Stewar W; Eisenhauer E;
    Invest New Drugs; 2002 Nov; 20(4):431-7. PubMed ID: 12448662
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Matrix metalloproteinase inhibitors: present achievements and future prospects.
    Denis LJ; Verweij J
    Invest New Drugs; 1997; 15(3):175-85. PubMed ID: 9387040
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196.
    Sparano JA; Bernardo P; Stephenson P; Gradishar WJ; Ingle JN; Zucker S; Davidson NE
    J Clin Oncol; 2004 Dec; 22(23):4683-90. PubMed ID: 15570070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Matrix metalloproteinase inhibitors (MMPIs): the beginning of phase I or the termination of phase III clinical trials.
    Pavlaki M; Zucker S
    Cancer Metastasis Rev; 2003; 22(2-3):177-203. PubMed ID: 12784996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation.
    Levin VA; Phuphanich S; Yung WK; Forsyth PA; Maestro RD; Perry JR; Fuller GN; Baillet M
    J Neurooncol; 2006 Jul; 78(3):295-302. PubMed ID: 16636750
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metalloelastase (MMP-12) induced inflammatory response in mice airways: effects of dexamethasone, rolipram and marimastat.
    Nénan S; Lagente V; Planquois JM; Hitier S; Berna P; Bertrand CP; Boichot E
    Eur J Pharmacol; 2007 Mar; 559(1):75-81. PubMed ID: 17234180
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Matrix metalloproteinase inhibitors for therapy of cancer].
    Sone S; Shiraga M
    Nihon Rinsho; 2001 Apr; 59 Suppl 4():431-7. PubMed ID: 11424420
    [No Abstract]   [Full Text] [Related]  

  • 52. Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer.
    Jones PH; Christodoulos K; Dobbs N; Thavasu P; Balkwill F; Blann AD; Caine GJ; Kumar S; Kakkar AJ; Gompertz N; Talbot DC; Ganesan TS; Harris AL
    Br J Cancer; 2004 Jul; 91(1):30-6. PubMed ID: 15162145
    [TBL] [Abstract][Full Text] [Related]  

  • 53. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
    Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel matrix metalloproteinase inhibitor, FYK-1388 suppresses tumor growth, metastasis and angiogenesis by human fibrosarcoma cell line.
    Shinoda K; Shibuya M; Hibino S; Ono Y; Matsuda K; Takemura A; Zou D; Kokubo Y; Takechi A; Kudoh S
    Int J Oncol; 2003 Feb; 22(2):281-8. PubMed ID: 12527923
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intraosseous infusion of the distal phalanx compared to systemic intravenous infusion for marimastat delivery to equine lamellar tissue.
    Underwood C; Collins SN; van Eps AW; Mills PC; Allavena RE; Bailey SR; Medina Torres CE; Meizler A; Pollitt CC
    Vet J; 2015 Sep; 205(3):357-63. PubMed ID: 26073286
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel matrix metalloproteinase inhibitor [18F]marimastat-aryltrifluoroborate as a probe for in vivo positron emission tomography imaging in cancer.
    auf dem Keller U; Bellac CL; Li Y; Lou Y; Lange PF; Ting R; Harwig C; Kappelhoff R; Dedhar S; Adam MJ; Ruth TJ; Bénard F; Perrin DM; Overall CM
    Cancer Res; 2010 Oct; 70(19):7562-9. PubMed ID: 20729277
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteers.
    Millar AW; Brown PD; Moore J; Galloway WA; Cornish AG; Lenehan TJ; Lynch KP
    Br J Clin Pharmacol; 1998 Jan; 45(1):21-6. PubMed ID: 9489589
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A synthetic matrix metalloproteinase inhibitor prevents squamous carcinoma cell proliferation by interfering with epidermal growth factor receptor autocrine loops.
    O-Charoenrat P; Rhys-Evans P; Eccles S
    Int J Cancer; 2002 Aug; 100(5):527-33. PubMed ID: 12124801
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vorinostat.
    Grant S; Easley C; Kirkpatrick P
    Nat Rev Drug Discov; 2007 Jan; 6(1):21-2. PubMed ID: 17269160
    [No Abstract]   [Full Text] [Related]  

  • 60. Phase II study of high central dose Gamma Knife radiosurgery and marimastat in patients with recurrent malignant glioma.
    Larson DA; Prados M; Lamborn KR; Smith V; Sneed PK; Chang S; Nicholas KM; Wara WM; Devriendt D; Kunwar S; Berger M; McDermott MW
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1397-404. PubMed ID: 12459362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.